# A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers

> **NCT01049035** · PHASE2 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 580 (actual)

## Conditions studied

- Meningitis
- Meningococcal Infection

## Interventions

- **BIOLOGICAL:** Quadrivalent Meningococcal Polysaccharide (A, C, Y, and W-135) Tetanus Protein Conjugate
- **BIOLOGICAL:** Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus B Conjugate (Tetanus Toxoid Conjugate) Vaccine Combined (DTaP-IPV/Hib combined)
- **BIOLOGICAL:** M-M-RII-Measles, Mumps, and Rubella Virus Vaccine Live
- **BIOLOGICAL:** Varicella Virus Vaccine Live
- **BIOLOGICAL:** Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)
- **BIOLOGICAL:** Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)
- **BIOLOGICAL:** Rotavirus Vaccine
- **BIOLOGICAL:** Hepatitis B Vaccine

## Key facts

- **NCT ID:** NCT01049035
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12-16
- **Primary completion:** 2012-02-13
- **Final completion:** 2012-02-13
- **Target enrollment:** 580 (ACTUAL)
- **Last updated:** 2022-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01049035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01049035, "A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01049035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*